C Manegold

Summary

Country: Germany

Publications

  1. ncbi request reprint [Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)]
    C Manegold
    Thoraxklinik der LVA, Heidelberg
    Med Klin (Munich) 93:16-21. 1998
  2. ncbi request reprint The causes and prognostic significance of low hemoglobin levels in tumor patients
    C Manegold
    Sektion Onkologie, Thoraxklinik Heidelberg Rohrbach, Germany
    Strahlenther Onkol 174:17-9. 1998
  3. ncbi request reprint Gemcitabine in non-small cell lung cancer (NSCLC)
    C Manegold
    Thoraxklinik der LVA, University Teaching Hospital, Heidelberg, Germany
    Invest New Drugs 18:29-42. 2000
  4. ncbi request reprint Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase II trial
    C Manegold
    Thoraxklinik Heidelberg GmBH, Germany
    Ann Oncol 11:435-40. 2000
  5. ncbi request reprint Chemotherapy for advanced non-small cell lung cancer: standards
    C Manegold
    Department of Internal Medicine Medical Oncology, Thoraxklinik Heidelberg, Amalienstr 5, D 69126, Heidelberg, Germany
    Lung Cancer 34:S165-70. 2001
  6. ncbi request reprint Chemotherapy for advanced non-small cell lung cancer
    C Manegold
    Department of Internal Medicine/Medical Oncology, Thoraxklinik, Heidelberg, Germany
    Semin Oncol 28:1-6. 2001
  7. ncbi request reprint Treatment of elderly patients with non-small-cell lung cancer
    C Manegold
    Thorax Klinik-Heidelberg GmbH, Heidelberg, Germany
    Oncology (Williston Park) 15:46-51. 2001

Detail Information

Publications7

  1. ncbi request reprint [Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)]
    C Manegold
    Thoraxklinik der LVA, Heidelberg
    Med Klin (Munich) 93:16-21. 1998
    ..Up until now it has primarily been used in clinical studies for both single agent- and combination chemotherapy being tested in a variety of different treatment regimens not only for advanced disease but also for early stage NSCLC...
  2. ncbi request reprint The causes and prognostic significance of low hemoglobin levels in tumor patients
    C Manegold
    Sektion Onkologie, Thoraxklinik Heidelberg Rohrbach, Germany
    Strahlenther Onkol 174:17-9. 1998
    ..Given the risks associated with transfusions, especially for tumor patients, recombinant erythropoietin holds promise for raising hemoglobin levels and thereby improving therapeutic efficacy and survival...
  3. ncbi request reprint Gemcitabine in non-small cell lung cancer (NSCLC)
    C Manegold
    Thoraxklinik der LVA, University Teaching Hospital, Heidelberg, Germany
    Invest New Drugs 18:29-42. 2000
    ..Investigations combining gemcitabine with radiation therapy are on-going. The following review will summarize results from representative Phase I/II and III studies using gemcitabine for NSCLC patients...
  4. ncbi request reprint Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase II trial
    C Manegold
    Thoraxklinik Heidelberg GmBH, Germany
    Ann Oncol 11:435-40. 2000
    ..To evaluate the activity of MTA plus cisplatin in chemotherapy-naive patients with non-small cell lung cancer (NSCLC)...
  5. ncbi request reprint Chemotherapy for advanced non-small cell lung cancer: standards
    C Manegold
    Department of Internal Medicine Medical Oncology, Thoraxklinik Heidelberg, Amalienstr 5, D 69126, Heidelberg, Germany
    Lung Cancer 34:S165-70. 2001
    ..Both studies demonstrated that Docetaxel 75 mg/m2 given every 3 weeks significantly prolongs survival, and offers clinically meaningful benefits to patients who have an acceptable performance status...
  6. ncbi request reprint Chemotherapy for advanced non-small cell lung cancer
    C Manegold
    Department of Internal Medicine/Medical Oncology, Thoraxklinik, Heidelberg, Germany
    Semin Oncol 28:1-6. 2001
    ..This report, however, focuses on the use of chemotherapy in advanced disease. Semin Oncol 28 (suppl 7):1-6...
  7. ncbi request reprint Treatment of elderly patients with non-small-cell lung cancer
    C Manegold
    Thorax Klinik-Heidelberg GmbH, Heidelberg, Germany
    Oncology (Williston Park) 15:46-51. 2001
    ..Clinical research with the new cytotoxic agents should be intensified to further define the most appropriate use for these drugs as single agents or in combination for the treatment of elderly patients...